GTx, Inc. (NASDAQ:GTXI)
CAPS Rating:
A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.
RSS Headlines
Fool UK
Recs
inisder bought 4.6m worth of shares at 4.75 each. cash rich, zero debt.